IQLT - ETF AI Analysis

Top Page

iShares MSCI Intl Quality Factor ETF (IQLT)

Rating:68Neutral

Price Target:―

IQLT’s rating suggests it is a solid-quality international ETF, mainly driven by strong, financially robust companies like Novartis and AstraZeneca, which benefit from profitable operations, healthy balance sheets, and supportive earnings call sentiment. Other major holdings such as ASML, Roche, Shell, ABB, and Zurich Insurance also add to the fund’s quality profile, though some face valuation concerns or bearish technical trends that slightly weigh on the overall rating. The main risk factor is that several key holdings show signs of being overvalued or technically weak in the short term, which could increase volatility even though their long-term fundamentals are strong.

Positive Factors

Strong Recent Performance

The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.

Quality Leaders in Top Holdings

Several major positions, such as ASML and Roche, have delivered strong or steady performance, helping support the fund’s overall returns.

Broad International Diversification

Holdings spread across many countries and sectors, with no single country or industry dominating, help reduce the impact of local or sector-specific downturns.

Negative Factors

Mixed Performance Among Top Holdings

Some large positions, including Allianz, Shell, AstraZeneca, Nestlé, and Zurich Insurance Group, have shown weak or negative performance, which can drag on the fund.

Heavy Financial Sector Exposure

A sizable allocation to financial stocks means the ETF may be more sensitive to interest rate changes and financial sector stress.

Moderate Expense Ratio

The fund’s expense ratio is not especially low for a large ETF, so fees may slightly reduce long-term returns compared with the cheapest alternatives.

IQLT vs. SPDR S&P 500 ETF (SPY)

AUM14.38B

RegionDeveloped Markets

Expense Ratio0.30%

Beta0.70

IssueriShares

Inception DateJan 13, 2015

Dividend Yield2.22%

Asset ClassEquity

Index TrackedWorld ex USA Sector Neutral Quality

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume5,287,836

30 Day Avg. Volume2,431,938

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

52.77

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering293

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

IQLT Summary

IQLT is the iShares MSCI Intl Quality Factor ETF, which follows the MSCI World ex USA Sector Neutral Quality index. It invests in “high-quality” companies from developed countries outside the U.S., focusing on firms with strong finances and steady earnings. The fund holds well-known names like Nestlé and AstraZeneca, and spreads money across many sectors such as financials, industrials, and technology. Someone might invest in IQLT to diversify beyond the U.S. and seek long-term growth from solid international companies. A key risk is that international stock prices can go up and down with global markets and currency moves.

How much will it cost me?The iShares MSCI Intl Quality Factor ETF (IQLT) has an expense ratio of 0.30%, which means you’ll pay $3 per year for every $1,000 invested. This is slightly higher than average for passively managed ETFs because it focuses on a specific strategy of selecting high-quality international stocks, which requires more specialized research and management.

What would affect this ETF?The iShares MSCI Intl Quality Factor ETF (IQLT) could benefit from continued global economic growth and increased demand for high-quality companies in developed markets outside the U.S., particularly in sectors like financials, technology, and healthcare. However, it may face challenges from rising interest rates, which could pressure profitability in certain sectors, and geopolitical risks or regulatory changes in key regions that could impact its top holdings like ASML, Shell, and Nestlé. Diversification across sectors and countries helps mitigate some risks but does not eliminate them entirely.

IQLT Top 10 Holdings

IQLT’s story is largely written in Europe, with a heavy tilt toward developed markets outside the U.S. ASML is the clear engine of the fund right now, rising on strong demand for its chip-making gear and giving the ETF a tech-powered boost. Health care is another key pillar: Roche and Novartis have been steadily climbing, helping offset softer spots. On the flip side, consumer giant Nestlé and insurer Zurich are lagging, acting like a bit of a brake. Overall, the fund is diversified but leans on quality European blue chips to drive returns.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
ASML	ASML Holding NV	6.02%	$861.97M	€464.34B	67.81%	76 Outperform
ALV	Allianz	2.43%	$348.16M	€140.80B	18.45%	67 Neutral
ROG	Roche Holding AG	2.35%	$336.29M	CHF279.83B	41.58%	73 Outperform
NOVN	Novartis AG	2.27%	$324.51M	CHF218.15B	19.92%	80 Outperform
SHEL	Shell (UK)	2.15%	$307.96M	£158.23B	4.31%	73 Outperform
AZN	AstraZeneca	2.01%	$287.50M	£210.86B	19.89%	80 Outperform
NESN	Nestlé SA	1.87%	$267.13M	CHF185.72B	12.00%	71 Outperform
ABB	ABB Ltd	1.76%	$252.21M	kr1.40T	32.56%	78 Outperform
ZURN	Zurich Insurance Group	1.64%	$235.41M	CHF78.11B	18.19%	78 Outperform
6857	Advantest	1.62%	$231.98M	¥18.66T	189.90%	75 Outperform

IQLT Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

45.63

Positive

100DMA

44.82

Positive

200DMA

43.32

Positive

Market Momentum

MACD

0.66

Negative

RSI

59.14

Neutral

STOCH

73.10

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IQLT, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 47.10, equal to the 50-day MA of 45.63, and equal to the 200-day MA of 43.32, indicating a bullish trend. The MACD of 0.66 indicates Negative momentum. The RSI at 59.14 is Neutral, neither overbought nor oversold. The STOCH value of 73.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IQLT.

IQLT Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
IQLT	―	―	$14.38B	0.30%	―
VEA	―	―	$209.76B	0.03%	―
SCHF	―	―	$59.19B	0.03%	―
SPDW	―	―	$36.32B	0.03%	―
IDEV	―	―	$26.22B	0.04%	―
DFAI	―	―	$14.02B	0.18%	―

Performance Comparison

IQLT

iShares MSCI Intl Quality Factor ETF

47.61

10.02

26.66%

VEA

Vanguard FTSE Developed Markets ETF

―

SCHF

Schwab International Equity ETF

―

SPDW

SPDR Portfolio Developed World ex-US ETF

―

IDEV

iShares Core MSCI International Developed Markets ETF

―

DFAI

Dimensional International Core Equity Market ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents